GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Clinical trials for GERD (GASTROESOPHAGEAL REFLUX DISEASE) explained in plain language.
Never miss a new study
Get alerted when new GERD (GASTROESOPHAGEAL REFLUX DISEASE) trials appear
Sign up with your email to follow new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New GERD pill aims to keep esophagus healed longer
Disease control Not yet recruitingThis study tests a new drug, linaprazan glurate, to see if it can keep the esophagus healed in people with GERD-related erosive esophagitis better than the standard treatment lansoprazole. About 1050 adults who have already healed their esophagitis will take either high or low do…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated May 26, 2026 11:12 UTC
-
New POEM technique aims to cut reflux risk in achalasia patients
Disease control Not yet recruitingThis study compares two versions of a minimally invasive surgery (POEM) for achalasia, a condition where the esophagus doesn't relax properly. The standard surgery often causes severe heartburn (GERD). The modified version tries to preserve certain muscle fibers to lower that ris…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: NA • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 26, 2026 11:07 UTC
-
New GERD drug aims to heal esophagus faster than current treatment
Disease control Not yet recruitingThis study tests a new medicine called linaprazan glurate to see if it heals esophagus damage from GERD better than the standard drug lansoprazole. About 500 adults with erosive esophagitis will take either the new drug or the standard one for up to 8 weeks. Doctors will use came…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated May 15, 2026 11:56 UTC